Disseminated histoplasmosis in infants

Pediatric Infectious Disease Journal

Volumn 18, Issue 12, 1999, Pages 1065-1068

  Odio, Carla M ^a   Navarrete, Marta ^a   Carrillo, Juan M ^a   Mora, Luis ^a   Carranza, Alfonso ^a  

^a Univ Auton de Ctro America   (Costa Rica)

Author keywords

Cell mediated immunodeficiency; Disseminated histoplasmosis; Infants; Reticuloendothelial system; Treatment

Indexed keywords

AMPHOTERICIN B; KETOCONAZOLE;

ARTICLE; BLOOD DISEASE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENDEMIC DISEASE; FEMALE; FEVER; HEPATOSPLENOMEGALY; HISTOPLASMOSIS; HUMAN; HYPERIMMUNOGLOBULINEMIA; IMMUNE DEFICIENCY; INFANT; MALE; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TREATMENT OUTCOME;

EID: 0032784809     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199912000-00007     Document Type: Article

References (32)

1. Darling ST. A protozoan general infection producing pseudo tubercles in the lungs: a focal necrosis in the liver, spleen, and lymph nodes. JAMA 1906;46:1283-6.
2. Goodwin RA, Des Prez RM. State of the art: histoplasmosis. Am Rev Respir Dis 1978;117:929-57.
3. Goodwin RA, Shapiro JL, Thurman GH, Thurman SS, Des Prez RM. Disseminated histoplasmosis: clinical and pathologic correlations. Medicine 1980;59:1-33.
4. Trejos A, Guardian JL. Generalized histoplasmosis in El Salvador, CA: a report of 13 cases in children under two years of age. Rev Biol Trop 1967;15:315-22.
5. Villela E, Para M. Histoplasmosis em crianca no estado des Minas Gerais. Rev Brasil Biol 1956;1:449-56.
6. Salfelder K, de Liscano TR. Lesiones histoplasmáticas como índice epidemiológico de la enfermedad en los Andes venezolanos. Mycopathologia 1965;26:19-30.
7. Jimenez E, Navarrete M, Mohs E, Carrillo JM, Lizano C. Histoplasmosis diseminada en niños. Bol Med Hosp Infant Mex 1980;37:927-35.
8. Hughes WT. Hematogenous histoplasmosis in the immuno-compromised child. J Pediatr 1984;105:569-75.
9. Wheat LJ, Salama TG, Eitzen HE, Kohler RB, French MLV, Bissecker JL. A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med 1981;94:331-7.
10. Sathapatayovong B, Batteiger BE, Wheat LJ, Slama TG, Wass JL. Clinical and laboratory features of disseminated histoplasmosis during two large outbreaks. Medicine (Baltimore) 1983;62:263-70.
11. Wheat LJ, Slama TG, Zeckel ML. Histoplasmosis in the acquired immunodeficiency syndrome. Am J Med 1985;78: 203-10.
12. Nickerson DA, Havens RA, Bullock WE. Immunoregulation in disseminated histoplasmosis: characterization of splenic suppressor cell populations. Cell Immunol 1981;60:287-97.
13. Bullock WE, Artz RP, Bhathena D, Tung KSK. Histoplasmosis: association with circulating immune complexes, eosinophilia and mesangiopathic glomerulonephritis. Arch Intern Med 1979;139:700-2.
14. Stobo JD. Immunosuppression in man: suppression by macrophages can be mediated by interaction with regulatory T cells. J Immunol 1977;119:918-24.
15. Couch JR, Abdow NL, Sagawa A. Histoplasma meningitis with hyperactive suppressor T cells in cerebrospinal fluid. Neurology 1978;28:119-23.
16. Mackinson JE. Histoplasmosis in Latin America. In: Proceedings of the Second National Conference on Histoplasmosis. Chap. 17. 1971:129-39.
17. Davis HV, Neff FC. Histoplasmosis of infancy. Am J Dis Child 1946;71:171-7.
18. Medoff G, Kobayashi GS. Histoplasmosis. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. Philadelphia: Saunders, 1987:1974-6.
19. Tesh RB, Shacklette MH, Diercks FH, Hirschl D. Histoplasmosis in children. Pediatrics 1964;33:894-903.
20. McDearman SC. An interpretation of serologic tests in Histoplasma capsulatum infections. In: Proceedings of the Second National Conference on Histoplasmosis. Chap 43. 1971: 358.
21. Wheat J, Morris LV, Kohler RB, et al. The diagnostic laboratory tests for histoplasmosis. Ann Intern Med 1982;97: 680-5.
22. Leggiadro RJ, Barrett FF, Hughes WT. Disseminated histoplasmosis of infancy. Pediatr Infect Dis J 1988;7:794-805.
23. Tobon AM, Franco L, Espinal D, et al. Disseminated histoplasmosis in children: the role of itraconazole therapy. Pediatr Infect Dis J 1996;15:1002-8.
24. Little J, Bruce J, Andrews H, Crawford K, McKinley G. Treatment of disseminated infantile histoplasmosis with amphotericin B. Pediatrics 1995;24:1-6.
25. Wheat LJ, Kohler RB, French MLB, et al. IgM and IgG histoplasmal antibody response in histoplasmosis. Am Rev Respir Dis 1983;128:65-70.
26. Taylor ML, Díaz S, Gonzalez PA, Sosa AC, Toriello C. Relationship between pathogenesis and immune regulation mechanisms in histoplasmosis: a hypothetical approach. Rev Infect Dis 1984;6:775-81.
27. Taylor ML, Eslava-Campos C, Garacía-Gonzalez R, Hernandez-Ramírez A. Relation between cellular and humoral immune response in mice immunized with Histoplasma capsulatum. In: Kuttin ES, Baun GL, eds. Human and animal mycology. Proceedings of the Seventh Congress of ISHAM, Jerusalem, Israel, March 11 to 16, 1979. New York: Elsevier/ North Holland,1980:97-101.
28. Bullock WE, Carlson EM, Gershon RK. The evolution of immunosuppressive cell populations in experimental mycobacterial infections. J Immunol 1978;120:1709-16.
29. Cunningham DS, Kuhn RE. Trypanosoma cruzi-induced suppressor substance: II. Regulatory activity. Immunogenetics 1980;10:557-71.
30. Ellner JJ. Suppressor adherent cells in human tuberculosis. J Immunol 1978;121:2573-9.
31. Newberry WM Jr, Chandler JW Jr, Chin TDY, Kirkpatrick CH. Immunology of the mycosis: depressed lymphocyte transformation in chronic histoplasmosis. J Immunol 1969;100: 436-43.
32. Yoshinoya S, Cox RA, Pope RM. Circulating immune complexes in coccidioidomycosis: detection and characterization. J Clin Invest 1980;66:655-63.